Raia Drogasil S.A. (BVMF:RADL3)
Brazil
· Delayed Price · Currency is BRL 16.06
+0.56 (3.61%)
May 12, 2025, 5:35 PM GMT-3
Raia Drogasil Revenue
Raia Drogasil had revenue of 10.05B BRL in the quarter ending March 31, 2025, with 10.44% growth. This brings the company's revenue in the last twelve months to 39.81B, up 13.29% year-over-year. In the year 2024, Raia Drogasil had annual revenue of 38.86B with 14.40% growth.
Revenue (ttm)
39.81B
Revenue Growth
+13.29%
P/S Ratio
0.69
Revenue / Employee
600.75K
Employees
64,758
Market Cap
27.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 38.86B | 4.89B | 14.40% |
| Dec 31, 2023 | 33.97B | 4.91B | 16.88% |
| Dec 31, 2022 | 29.07B | 4.94B | 20.48% |
| Dec 31, 2021 | 24.13B | 4.06B | 20.23% |
| Dec 31, 2020 | 20.07B | 2.50B | 14.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 51.35B |
| Hypera | 6.70B |
| Fleury | 7.80B |
| Odontoprev | 2.46B |
| Oncoclínicas do Brasil Serviços Médicos | 6.23B |
| Blau Farmacêutica | 1.77B |
| Diagnósticos da América | 15.32B |
| Empreendimentos Pague Menos | 13.13B |
Raia Drogasil News
- 3 days ago - Raia Drogasil: Valuation Burn Now, Healthy Gains Later - Seeking Alpha
- 2 months ago - Raia Drogasil SA (RADLY) Q4 2024 Earnings Call Highlights: Expansion and Digital Growth Amid ... - GuruFocus
- 5 months ago - Raia Drogasil S.A. goes ex dividend tomorrow - Seeking Alpha
- 7 months ago - Raia Drogasil goes ex dividend tomorrow - Seeking Alpha